The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours

Sarah P. Blagden(Churchill Hospital), Michael J. Seckl(Charing Cross Hospital), E.S. Newlands(Charing Cross Hospital), D Short(Imperial College Healthcare NHS Trust), S Fuller(Charing Cross Hospital), Rosemary A. Fisher, Marianne Foskett(Charing Cross Hospital)

British Journal of Cancer

January 1, 2002

10.1038/sj.bjc.6600041

Cited by 50

Related Papers

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

|Nature reviews. Cancer|2015|1.4k

Guidelines for the conduct of clinical trials for spinal cord injury as developed by the ICCP panel: spontaneous recovery after spinal cord injury and statistical power needed for therapeutic clinical trials

|Spinal Cord|2006|872

Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

|Annals of Oncology|2013|379

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

|The Lancet|2019|223

Performance status score: do patients and their oncologists agree?

|British Journal of Cancer|2003|222